Windtree Therapeutics will be delisted from the Nasdaq Stock Market on August 21, 2025, after failing to meet minimum bid price requirements. The company is transitioning to over-the-counter […]
Windtree Faces Demise From Nasdaq Delisting Over Bid Price Rule Failure
Nasdaq has announced plans to remove Windtree Therapeutics (WINT) from trading, citing non-compliance with listing regulations. The company’s failure to maintain a minimum bid price above $1 per […]
Windtree Therapeutics Faces Delisting After Major BNB Investment
Nasdaq has delisted Windtree Therapeutics, citing a 77% stock decline caused by the company’s decision to invest heavily in Binance Coin (BNB). CEO Jed Latkin confirmed these reports […]
Windtree Therapeutics Delists from Nasdaq after BNB Treasury Strategy Fails
Windtree Therapeutics’ Nasdaq listing was terminated on August 21, 2025, following a failed pivot to a $700 million BNB-focused treasury. The move resulted in a drastic decline of […]
Windtree Therapeutics Faces Delisting from Nasdaq, Shares Plunge Amidst Financial Struggles
Windtree Therapeutics is facing delisting from the Nasdaq Capital Market after failing to meet a minimum $1 bid price requirement for 30 consecutive business days. The company’s shares […]
Windtree Therapeutics Delists from Nasdaq: What You Need to Know
Nasdaq has announced that Windtree Therapeutics will be delisted from the exchange, effective August 21, 2025. This decision comes due to the company failing to meet the minimum […]
Windtree Therapeutics to Delist from Nasdaq, Moves to OTC Market
Nasdaq has officially delisted Windtree Therapeutics from its market effective August 21st, 2025, citing noncompliance with minimum share price requirements. However, this move won’t negatively impact BNB, a […]
Windtree Therapeutics Delisting: Nasdaq Rule Violation Leads to Market Volatility
The biotechnology firm, Windtree Therapeutics, has been delisted from the Nasdaq Stock Exchange due to failing to maintain a minimum bid price of $1 for 30 consecutive business […]
Nasdaq Delists Windtree Therapeutics; Stock Plummets 76%
Windtree Therapeutics, a company focused on developing treatments for cardiovascular diseases, will be delisted from the Nasdaq Stock Market on August 21, 2025. This follows noncompliance with listing […]